Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(63 sites)
United States
Sarah Cannon Research Institute (Scri) At Health One, Denver, Colorado Florida Cancer Specialists and Research Institute, Lake Mary, Florida Karmanos Cancer Institute, Detroit, Michigan Washington University School of Medicine, St Louis, Missouri Duke Cancer Center, Durham, North Carolina James Cancer Hospital and Solove Research Institute, Columbus, Ohio Scri Oncology Partners, Nashville, Tennessee The University of Texas Md Anderson Cancer Center, Houston, Texas Next Dallas, Irving, Texas Next Oncology, San Antonio, Texas Australia
Blacktown Cancer and Haematology Centre, Blacktown, New South Wales Southern Highlands Private Hospital, Bowral, New South Wales Concord Repatriation General Hospital, Concord, New South Wales Macquarie University, North Ryde, New South Wales Townsville University Hospital, Douglas, Queensland Genesiscare St Andrews, Adelaide, South Australia Austin Health, Heidelberg, Victoria Peter Maccallum Cancer Centre, Melbourne, Victoria Brazil
Fundacao Pio Xii Hospital de Amor de Barretos, Barretos Hospital Sirio Libanes Brasilia, Brasília Centro de Pesquisas Oncologicas Cepon, Florianópolis Liga Norte Riograndene Contra O Cancer, Natal Fundacao Universidade de Caxias Do Sul Instituto de Pesquisas Em Saude, Petrópolis Hospital Sao Lucas Da Pucrs Uniao Brasileira de Educacao E Assistencia, Porto Algre Instituto Nacional de Cancer, Rio de Janeiro Instituto Dor de Pesquisa E Ensino Hospital Sao Rafael, Salvador Icesp Instituto Do Cancer Do Estado de Sao Paulo Octavio Frias de Oliveira, São Paulo Clinica de Pesquisa E Centro de Estudos Em Oncologia Ginecologica E Mamaria, São Paulo Hospital Israelita Albert Einstein, São Paulo China
Beijing Cancer Hospital, Beijing, Beijing Municipality Fujian Cancer Hospital, Fuzhou, Fujian Sun Yat Sen Memorial Hospital, Sun Yat Sen University (South), Guangzhou, Guangdong Harbin Medical University Cancer Hospital, Harbin, Heilongjiang The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang, Jiangxi Liaoning Cancer Hospital and Institute, Shenyang, Liaoning Fudan University Shanghai Cancer Centerpudong, Shanghai, Shanghai Municipality France
Centre de Lutte Contre Le Cancer Institut Bergonie, Bordeaux Centre Francois Baclesse, Caen Centre Oscar Lambret, Lille Institut Paoli Calmettes, Marseille Centre Eugene Marquis, Rennes Institut de Cancerologie de Louest, Saint-Herblain Institut Gustave Roussy, Villejuif Japan
Nagoya University Hospital, Nagoya, Aichi-ken National Cancer Center Hospital East, Kashiwa, Chiba Shizuoka Cancer Center, Suntogun, Shizuoka Malaysia
Pulau Pinang Hospital, George Town University Malaya Medical Centre, Kuala Lumpur Sarawak General Hospital, Kuching National Cancer Institute (Institut Kanser Negara), Putrajaya Moldova
The Institute of Oncology, Arensia Exploratory Medicine, Chisinau New Zealand
Harbour Cancer and Wellness, Auckland Nzcr Christchurch, Christchurch South Korea
Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do Gachon University Gil Medical Center, NamdongGu, Incheon Gwang'yeogsi Samsung Medical Center, GangnamGu, Seoul Teugbyeolsi The Catholic University of Korea, Seoul St Marys Hospital, SeochoGu, Seoul Teugbyeolsi Severance Hospital Yonsei University Health System, SeodaemunGu, Seoul Teugbyeolsi Korea University Anam Hospital, SeongbukGu, Seoul Teugbyeolsi Seoul National University Hospital, Seoul, Seoul Teugbyeolsi Asan Medical Center, SongpaGu, Seoul Teugbyeolsi Thailand
Srinagarind Hospital (Khon Kaen University), Muang